US Stock MarketDetailed Quotes
SRRK Scholar Rock
- 14.160
- +0.150+1.07%
Trading May 15 15:00 ET
1.13BMarket Cap-6775P/E (TTM)
14.670High13.840Low626.15KVolume14.400Open14.010Pre Close8.85MTurnover1.25%Turnover RatioLossP/E (Static)79.75MShares21.17052wk High6.18P/B708.82MFloat Cap5.56052wk Low--Dividend TTM50.06MShs Float70.000Historical High--Div YieldTTM5.92%Amplitude4.325Historical Low14.142Avg Price1Lot Size
About Scholar Rock Company
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
Company Profile
SymbolSRRK
Company NameScholar Rock
Listing DateMay 24, 2018
Issue Price14.00
Founded2012
CEODr. Jay T. Backstrom, M.D.,M.P.H.
MarketNASDAQ
Employees150
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address301 Binney Street,3rd floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-857-259-3860
Websitehttp://www.scholarrock.com
Company Executives
- Name
- Position
- Salary
- Dr. Jay T. Backstrom, M.D.,M.P.H.
- Director, President and Chief Executive Officer
- 4.11M
- Dr. Jing L. Marantz, M.D.,PhD
- Chief Medical Officer
- --
- Tracey Sacco
- Chief Commercial Officer
- 2.28M
- Caryn Parlavecchio
- Chief Human Resources Officer
- --
- Edward H. Myles
- Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
- 2.01M
- Mohammed Qatanani
- Chief Scientific Officer
- --
- David L. Hallal
- Chairman of the Board
- 416.70K
- Dr. Jeffrey S. Flier, M.D.
- Independent Director
- 305.70K
- Katie Peng
- Independent Director
- --
- Amir H. Nashat, PhD
- Independent Director
- 295.70K
- Kristina M. Burow
- Independent Director
- 300.34K
- Richard H. Brudnick
- Independent Director
- 367.96K
- Dr. Srinivas Akkaraju, M.D.,PhD
- Independent Director
- 291.23K
- Dr. Akshay K. Vaishnaw, M.D.,PhD
- Independent Director
- 298.20K
- Joshua Reed
- Independent Director
- 305.70K
- Michael Gilman, PhD
- Independent Director
- 299.20K
- Junlin Ho
- General Counsel and Corporate Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg